/PRNewswire/ MedC Biopharma today announced a partnership with A2W Pharma of Malta in the development of MedC s proprietary novel cannabinoid formulations.
C'Israël. L'usage du cannabis à des fins médicales en Israël. – IsraelValley israelvalley.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israelvalley.com Daily Mail and Mail on Sunday newspapers.
MedC Biopharma and Sana Healthcare Partner to Advance Skin Oncology Platform
News provided by
Share this article
Share this article
TORONTO, Jan. 12, 2021 /PRNewswire/ MedC Biopharma Corporation ( MedC ), a Canadian clinical-stage biopharmaceutical company that develops and commercializes products containing cannabinoids and/or other natural compounds, is pleased to announce a strategic partnership agreement with Sana Healthcare ( Sana ). Sana is a specialist importer, wholesaler and distributor of cannabis-based medicines and supports biopharmaceutical companies in selecting and then pursuing the most appropriate clinic pathways in the UK. The partnership will advance the development of MedC s product platform for the treatment of Cutaneous T-Cell Lymphoma (CTCL) Sezary Syndrome.